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ABSTRACT  
Pelvic inflammatory diseases, a leading gynecological problem worldwide, are associated with socio-economic 
and psychological costs. A retrospective study of 1350 high vaginal swabs analyzed between Jan-Dec. 2005, 
showed that 845 (62.8%) were positive for 9 microorganisms by culture/or wet preparation. Microbial growth 
was found in 645 (76.3%) cases.  Polymicrobial growth was found in 90 (10.7%), fungal growth in 110 (13.0%) 
cases, and 3(0.4%) yielded anaerobic growth. Staphylococcus aureus accounted for 355 (42.0%) cases, followed 
by Escherichia coli 190 (22.5%), Trichomonas vaginalis 100 (11.8%) Candida spp and Neisseria gonorrhoeae 70 
(8.3) and the least, Pseudomonas spp 5 (0.6%)  Microbial-associated infection was prominent in the group 21-30 
years old (46.6%) and 31-40 (23.9%) years respectively. Antibiotic susceptibility pattern showed that mean 
susceptibility greater than 50% were recorded with ofloxacin 80%, ceftazidime 80%, rifampicin 81.9% 
compared to mean susceptibility less that 50% recorded with trimethoprim-sulthamethoxazole 34.7%, and 
ampicillin 26.1%. 
 
In conclusion, the reported microbial-associated infection in PID with a prevalence of 62.8% is of public health 
importance. Early diagnosis of causative agents and prompt institution of chemotherapeutic agents will help to 
prevent clinical complications that are expensive to treat.  
 




Pelvic inflammatory disease (PID), is an 
infection of the upper genital tract in women that 
include endometritis, parametritis, salpingitis, 
oophoritis, tubo-ovarian abscess and peritonitis 
(1,2). It accounts for 5-20% of hospital 
admissions for gynecological problems in 
general/gynecological clinics worldwide (3). In 
USA, infertility that affects approximately 10-
15% of all couples attribute tubal damage due to 
pelvic infection (4,5). Clinical presentation 
varies in severity, and ranges from sub clinical, 
asymptomatic infections exerting medical and 
psychological cost that include chronic pelvic 
pain, ectopic pregnancy and infertility (1). It has 
been associated with increase risk of ovarian 
cancer6-8. The pathogenesis is complex 
interaction of genetic, immunological and 
bacterial virulence factors (9).  
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The prevalence and incidence of PID varies 
greatly, because of significant misdiagnosed/or 
unreported cases. In developed countries, annual 
incidence of PID increased in women aged 15-45 
years, with peak of infection in 20-24 years (10). 
Polymicrobial agents are associated and initiated 
pathogenesis of PID, particularly in presence of 
facultative aerobic and anaerobic bacterial 
isolates (11-14), with Niesseria. Gonorrhoea and 
Chlamudia tracomatis as leading pathogens, 
accounted for 60-80% in women of aged less 
than 25 years12-14. Other less pathogenic 
mycoplasma, and endogenous aerobic and 
anaerobic bacteria have also been implicated 
(15). Co-existence of sexually transmitted 
diseases (STD) etiological agent in genital tract 
predispose the women to acquisition of PID 
(1,16). Korn et al (17) reported that clinical 
presentation and course of PID in women with 
sy,ptomatic HIV disease and/or severe immune 
suppression may be more aggressive than in HIV 
negative women.  
 
Clinical diagnosis is rather difficult, as no single 
clinical and laboratory test in definite as gold 
standard, thus comibination of test seems to 
impove sensitivity and specificity (18,19). 
Epidemiological and microbiological indices 
associated with PID are important source of 
preventable reproductive infertility in women, 
and other clinical squealed. Little information is 
available on PID epidemiology in this 
environment, this there is no baseline in 
assessment of its relationship in case of 
infertility and HIV infection.  
 
Early diagnosis/treatment of PID could stemmed 
down the effect on the fallopian tubes; and in 
case of microbe-related inflammation and tubal 
necrosis can similarly precedes manifestation of 
symptoms, especially in aetiological agent due to 
chlamydial3. Prompt diagnosis and institution of 
appropriate antibiotic therapy would prevent 
possible sequelae of PID. The retrospective 
study examined the aetiological spectrum in high 
vaginal swabs of pelvic inflammatory diseases in 
this environment.  
 
MATERIALS AND METHODS  
Study Site  
The retrospective study was conducted in 
Federal Medical Center, Nguru, between Jan-
Dec 2005, which involved the Pathology and 
Obsterictic/Gynecology departments. The 
patients folder presented at the general out-
patients/gynecology clinic, with clinical 
complaint suggestive of pelvic inflammatory 
diseases, ranged from pelvic viginal discharge to 
lower abdominal pain, with high vaginal swabs 
collected and sent for bacteriological analysis. 
Criteria of inclusion are consecutive non-
duplicate high vaginal swabs, repeated swab 
analysis and mixed growth of doubtful 
significance were excluded. Information 
retrieved from the patients folder included age, 
sex, and clinical complaint. 
 
Processing of the Specimens  
The high vaginal swab was processed, with 
inoculation on Blood, Chocolate and Sabouraud 
agar plates, incubated at 370C for 24hours. 
Bacterial/yeast were identified by standard 
bacteriogical and mycological techniques (20-
22). Yeats were further identified by germ tube 
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test. Direct smear was prepared stained by Gram 
methods, and wet preparation of the specimen 
for parasitic examination. Antibiotic 
susceptibility testing was determined by disc 
diffussion23, using the following antibiotic 
discs, ofloxacin )OFX), ciprofloxacin (CPX), 
perfloxacin (PEF), ceftazidime (CAZ), 
cefuroxime (CXM), rifampicin(RF), 
strepromycin(S), tetracycline (TET), 
trimethoprim sulthamethoxazole (SXT), 
anpicillin (AMP), gentamycin (CN), 
erythromycin (E), and augmentime(AU). The 
zone of inhibition of the disc was measured to 
determined whether resistant or sensitive in 
accordance to NCCLS guidelines (23).  The 
mean susceptibility percentage of each antibiotic 
was calculated as the number of bacterial isolates 
susceptible divided by total number of bacterial 
isolates tested multiply by 100.  
 
Data Analysis  
Data and information retrieved from patients 
flders were entered into study datavasem using 
SPSS version13.0. The value were expressed 
mean and percentage, and appropriate statistical 
package where necessary.  
 
RESULTS  
Of the 1350 high vaginal swabs results analyzed, 
846 (62.8%) were positive for 9 microorganisms 
by culture/or wet preparation examination (7 
bacterial pathogens, 1 fungi and 1 protozoan) as 
in table 1. The means age of the patient was 22.4 
+ 2.7 years. The ratio of gram-negative bacteria 
ratio was 1:2:5 Monomicrobic growth was 
recorded in 645 (76.3%), polymicrobic growth in 
90 (10.7%) and bacterofungal in 110 (12.0%) 
cases. Three (0.4%) cases yielded anaerobic 
growth.  
 
Staphylococcus aureus was the accounted for 
355 (41.9%) cases, followed by Escherichia coli 
190 (22.4%), Trichomonas vaginalis 100 
(11.8%), Neisseria gonorrhoeae and Candida 
spp 70 (8.3%) repetitively. Microbial-associate 
infection distribution, in accordance with the age 
group of the patients studied (tableII), frequency 
of occurrence was predominant with the age 
group 21-30 (46.7%) and 31-40(23.9%) years 
and least in 10-20(8.1%) and >51(6.4%) years 
respectively. There was statistically significant 
difference between microbial infection and the 
age-group (p<0.05). Similarly, there was a 
decreasing trend pattern in frequency of 
occurrence of microorganism and age-group.  
 
Antibiotic susceptibility pattern of bacterial 
isolates as shown in table III, showed that mean 
susceptibility percentage greater than 50 was 
observed with ofloxacin, gentamycin, 
ciprofloxacin, pefloxacin, rifampicin, 
cefuroxime, ceftazidime, erythromycin and 
streptomycin, and less than 50 in trimethoprim-




Table I: Frequency of occurrence of Microorganisms Isolated 
Microorganisms       Frequency of Occurrence (%) 
Gram-positive bacteria (n=370) 
Staphylococcus aureus    355 (42.0) 
 Streptococcus spp.    15 (1.8) 
 
Gram-negative bacteria (n=305) 
Escherichia coli     190(22.5) 
Neisseria gonorrohea     70(8.3) 
Klebsiella spp     30(3.6) 
Proteus spp.     10(1.2) 
Pseudomonas spp.    5(0.6) 
Anaerobic bacteria     3(0.4) 
 
Fungi (n=70) 
Candida spp     70(8.3) 
 
Parasites (n=100) 
Trichomonas vaginalis     100(11.8) 
 
Total      848 
 




















10-20 30 - - 10 - 1 5 16 7  69 
21-30 115 10 15 95 8 - 40 74 37 2 396 
31-40 100 3 8 45 2 - 15 8 21 1 205 
41-50 75 2 5 25 - 1 10 2 5 - 125 
>51 35 - 2 15 - 3 - - - - 55 
Total 355 15 30 190 10 5 70 100 70 3 848 
 
Table III: Antibiotic susceptibility pattern of the bacterial isolates (% susceptibility)  
 

















S.aureus 90 65 80 89 25 21 89 75 60 70 85 72 45 
E.coli 82 70 75 83 43 26 78 65 72 73 78 80 54 
Kleb spp 78 56 78 78 45 35 85 67 56 67 76 82 42 
Strep spp 90 82 89 79 50 42 90 90 80 80 84 79 35 
Proteus spp 75 67 75 74 35 22 76 69 67 67 73 80 45 
Pseudo spp 60 42 73 67 20 12 65 52 45 45 75 82 38 
N.gonorroheae 85 65 73 74 25 25 90 68 50 78 80 85 38 























Clinical significance of PID becomes 
pronounced because its association with sexually 
transmitted diseases/HIV/AIDS infections. 
Particularly in asymptomatic individuals who 
may laer present with various complications 
irrespective of the social and psychological cost 
(19,24). Consequently, a dramatic increase in the 
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the incidence of PID has led to a parallel  
increase in infertility (25).  
 
The reported prevalence of microbial-associated 
infection in PID of 62.8% of our patients is high. 
Our report is similar to the rates reported in 
similar studies conducted in Sokoto (26) and 
Gombe (27) of same geographical zone. 
However, comparison of PID prevalence in 
studies conducted at different geographical 
location/countries might be rather difficult, 
because of certain inherent biases involved, 
particularly presence of PID-related infections 
(10,28-30). Similarly, PID prevalence are 
influenced by variation in case definition 
(particularly between different clinical settings), 
changes in disease chronicity associated with 
clinically mild Chlamydia infection, variation in 
health seeking behaviour and increase 
management of PID in outpatient setting (31,32).  
 
The frequency of occurrence of microbial-
associated infection was high in the age group of 
21-30(46.7%) and 31-40(23.9%) years. This 
finding simply confirms reported findings that 
highest PID prevalence and highest rate of 
increase are associated and seen in the 16-24 
years age groups, and substantial numbers of 
bacterial sexually transmitted infection are high 
these age group (16-193,6,19,33). Also PID 
accounts for approximately 60% of 
gynecological problems in women aged less than 
25 years34. High prevalence of PID episodes in 
sexually active age group, re-emphases the 
correlation that co-existence of aetiological agent 
in the genital tract of the females predisposes to 
acquisition of PID (3,19,33-35). Some studies 
found demographic risk factors associated with 
PID, like sexual activity at young age, racial, and 
both pre-delivery history and post-partum 
diagnosis of chlamdyial and gonococci 
infections (36,37). However implication of these 
factors in this environment need further 
evaluation.  
 
From the present study, 10 microorganism (8 
bacterial pathogens, 1 fungal and 1 protozoan) 
were recorded.  S. aureus was the commonest 
and accounted for 42%, polymicrobial infection 
wasfound in 10.7% of cases and fungal infection  
in 13.0% of cases. This pattern simply confirms 
polymicrobial spectrum aetiology associated 
with pathogenesis of PID (11-14). S. aureus 
(42.0%), and E.coli (22.5%) were predominant 
bacterial isolates in the study, thesepathogens are 
most isolated in lower genital tract infections;  
and are responsible for a significant proportion 
of sexually transmitted diseases in Nigeria 
(26,38-40). The dominance of these bacterial 
pathogens as STI pathogens and their existence 
in the female genital tract clearly reaffirmed it  as 
a predisposing factor in acquisition of PID 
(1,16). Polymicrobial infection with other 
organisms such as anaerobes or faculitative 
aerobes may be initiated by gonorrhea, 
chlamydia or both (4,5,15,35). The low 
frequency of occurrence of N.gonorrhoeae as 
evident in this study, might probably be due to 
variation in the studied population, method of 
microbial investigation, variation in severity of 
the diseases, sampling technology and site of 
sampling (40). Technically, N. gonorrhoeae is 
highly fastidious fragile organisms, isolation is 
dependent on viability of the organism in the 
specimen, prompt delivery to specimen, and 
suitability of isolation medium. 
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Trichomonas vaginalis with a prevalence of 
11.6% in a center posed public health problem, 
because of close association of trichonomasis 
with HIV infection (42-45). T.vaginalis, is an 
irritating protozoan and is a common parasitic 
sexually transmitted disease reported  worldwide 
(45).  It is associated with inflammation of the 
cervix that may mimic cervical tenderness 
associated with PID (42). Buve et al (43) 
reported that trichomonasis incidence is higher in 
cities where there are higher number of HIV-
positive individuals. The high prevalence of 
trichomonasis and candiasis observed in this 
study basically revealed close association of poor 
personal hygienic conditions especially among 
the low socio-economic class and transmitted 
sexually, particularly in cases of multiple sex 
partners (10), with high probability of PID 
infection.  
 
The in-vitro antimicrobial susceptibility pattern 
of bacterial isolates revealed that mean 
percentage susceptibility of greater than 50% 
was observed with the fluoroquinolones 
(ofloxacin, ciprofloxacin, perfloxacin), 
cephalosporins (ceftfazidime, cefuroxime) and 
rifampicin ; and those less than 50% observed 
with gentamycin, erythromycin, augmentine and 
streptomycin, and least susceptibility observed in 
tetracycline (42.2%) trimethoprim-
sulphamethoxazole (34.7%) and ampicillin 
(2.1%). These antibiotic susceptibility patterns 
are similar to reports by other workers (26,27). 
The reduced susceptibility of antibiotics like 
ampicillin, tetracyclines anmd trimthoprim-
sulphamethoxazole, clearly revealed the abuse of 
these agents by self-medication practice, a 
common norm in most towns/cities in many 
developing countries. 
 
The fluoroquinolones showed favourable in-vitro 
susceptibility pattern that could serve as drugs of 
choice in PID treatment/management. However, 
documented studies have reported emergence of 
fluoroquinolones-resistant N.gonorrheae (3). 
With considerable numbers of antibiotics 
resistants strains, particularly of N. gonorrhoeae 
to penicillin and cephalosporins (particularly 1st 
generation), the used of second-generation 
cephalosporins that posses extended spectrum 
activity over wide ranged of microorganisms 
associated with PID3. from the in-vitro antibiotic 
susceptibility pattern of the study, gentamycin, 
erythromycin and streptomycin, could served the 
antibiotic of choice considering the relative cost 
and also posses extended-specturm activity. One 
of the greater threat to the efficacy of antibiotics 
is the presence/or emergence of resistant strain, 
thus, cautious approach is required in 
prescription/administration, as safeguard policy 
against possible emergence of muliresistant 
strain in a remote city, like Nguru.  
 
In conclusion, the prevalence of microbes-
associated PID of 62.8%, is high. It is important 
that microorganisms associated with PID are 
diagnosed early and appropriate chemotherauptic 
treatment/management commenced, as clinical 
complications are always very expensive to treat. 
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